| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.834 | 0.003 | 0.834 | 5 Hydroxytryptamine 2 antagonist | 0.436 0.008 DBMET01397 | ||
| 0.809 | 0.003 | 0.809 | 5 Hydroxytryptamine 2A antagonist | 0.42 0.006 DBMET01397 | ||
| 0.785 | 0.004 | 0.785 | 5 Hydroxytryptamine antagonist | 0.303 0.018 DBMET01397 | ||
| 0.757 | 0.004 | 0.757 | Dopamine D2 antagonist | 0.481 0.005 DBMET01397 | ||
| 0.726 | 0.004 | 0.726 | Dopamine antagonist | 0.416 0.007 DBMET01397 | ||
| 0.652 | 0.004 | 0.652 | 5 Hydroxytryptamine 2C antagonist | 0.216 0.015 DBMET01397 | ||
| 0.642 | 0.004 | 0.642 | 5 Hydroxytryptamine 2B antagonist | 0.266 0.017 DBMET01397 | ||
| 0.612 | 0.004 | 0.612 | 5 Hydroxytryptamine 1A antagonist | 0.177 0.017 DBMET01397 | ||
| 0.61 | 0.004 | 0.61 | 5 Hydroxytryptamine 1 antagonist | 0.176 0.019 DBMET01397 | ||
| 0.566 | 0.019 | 0.566 | Vasodilator, peripheral | 0.487 0.03 DBMET01397 | ||
| 0.545 | 0.005 | 0.545 | Alpha adrenoreceptor antagonist | 0.166 0.034 DBMET01397 | ||
| 0.539 | 0.004 | 0.539 | 5 Hydroxytryptamine 1A agonist | 0.341 0.005 DBMET01397 | ||
| 0.533 | 0.004 | 0.533 | Alpha 1 adrenoreceptor antagonist | 0.19 0.022 DBMET01397 | ||
| 0.498 | 0.004 | 0.498 | Mediator release inhibitor | 0.303 0.007 DBMET01397 | ||
| 0.433 | 0.005 | 0.433 | Dopamine D4 antagonist | 0.105 0.025 DBMET01397 | ||
| 0.416 | 0.005 | 0.416 | 5 Hydroxytryptamine 1 agonist | 0.241 0.009 DBMET01397 | ||
| 0.399 | 0.002 | 0.399 | Dopamine autoreceptor agonist | 0.163 0.003 DBMET01397 | ||
| 0.402 | 0.005 | 0.402 | Alpha 1a adrenoreceptor antagonist | 0.115 0.031 DBMET01397 | ||
| 0.409 | 0.015 | 0.409 | Cyclic AMP phosphodiesterase inhibitor | 0.234 0.072 DBMET01397 | ||
| 0.337 | 0.008 | 0.346 | Toll-Like receptor 9 antagonist | 0.346 0.007 DBMET01397 | DBMET01397 | |
| 0.324 | 0.007 | 0.324 | Alpha 1b adrenoreceptor antagonist | 0.125 0.028 DBMET01397 | ||
| 0.319 | 0.005 | 0.319 | 5 Hydroxytryptamine 1B antagonist | 0.091 0.028 DBMET01397 | ||
| 0.322 | 0.008 | 0.322 | Alpha 2b adrenoreceptor antagonist | 0.135 0.047 DBMET01397 | ||
| 0.301 | 0.005 | 0.301 | Dopamine D3 antagonist | 0.137 0.017 DBMET01397 | ||
| 0.303 | 0.013 | 0.303 | Antiadrenergic | 0.167 0.031 DBMET01397 | ||
| 0.3 | 0.013 | 0.3 | Adrenaline antagonist | 0.165 0.031 DBMET01397 | ||
| 0.285 | 0.006 | 0.285 | Dopamine D1 antagonist | 0.078 0.034 DBMET01397 | ||
| 0.324 | 0.048 | 0.324 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.228 0.128 DBMET01397 | ||
| 0.306 | 0.033 | 0.306 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.126 0.109 DBMET01397 | ||
| 0.306 | 0.035 | 0.306 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.159 0.117 DBMET01397 | ||
| 0.246 | 0.007 | 0.246 | Alpha 1d adrenoreceptor antagonist | 0.081 0.03 DBMET01397 | ||
| 0.279 | 0.042 | 0.279 | MAP-kinase-activated kinase 5 inhibitor | 0.229 0.074 DBMET01397 | ||
| 0.246 | 0.01 | 0.246 | Histamine H1 receptor antagonist | 0.193 0.015 DBMET01397 | ||
| 0.314 | 0.079 | 0.314 | Calcium channel activator | 0.28 0.113 DBMET01397 | ||
| 0.242 | 0.011 | 0.242 | 5 Hydroxytryptamine agonist | 0.118 0.028 DBMET01397 | ||
| 0.237 | 0.015 | 0.237 | Antihistaminic | 0.179 0.025 DBMET01397 | ||
| 0.271 | 0.05 | 0.271 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.243 | 0.027 | 0.243 | Acetylcholine M1 receptor antagonist | 0.143 0.081 DBMET01397 | ||
| 0.226 | 0.01 | 0.226 | 5 Hydroxytryptamine 7 antagonist | 0.128 0.02 DBMET01397 | ||
| 0.229 | 0.015 | 0.229 | Histamine antagonist | 0.165 0.026 DBMET01397 | ||
| 0.219 | 0.006 | 0.219 | 5 Hydroxytryptamine 1D antagonist | 0.077 0.033 DBMET01397 | ||
| 0.216 | 0.009 | 0.216 | Dopamine agonist | 0.159 0.014 DBMET01397 | ||
| 0.207 | 0.008 | 0.207 | DNA repair enzyme inhibitor | 0.12 0.073 DBMET01397 | ||
| 0.251 | 0.057 | 0.251 | Anticonvulsant | 0.224 0.068 DBMET01397 | ||
| 0.199 | 0.005 | 0.199 | Dopamine D2 agonist | 0.18 0.005 DBMET01397 | ||
| 0.229 | 0.038 | 0.229 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.245 | 0.054 | 0.245 | Platelet aggregation inhibitor | 0.166 0.11 DBMET01397 | ||
| 0.193 | 0.015 | 0.193 | Alpha 2a adrenoreceptor antagonist | |||
| 0.175 | 0.008 | 0.175 | Phosphodiesterase III inhibitor | 0.117 0.016 DBMET01397 | ||
| 0.175 | 0.015 | 0.175 | Protein kinase C zeta inhibitor | 0.103 0.047 DBMET01397 | ||
| 0.175 | 0.022 | 0.175 | Alpha 2 adrenoreceptor antagonist | |||
| 0.158 | 0.014 | 0.158 | Phosphodiesterase 3A inhibitor | 0.091 0.041 DBMET01397 | ||
| 0.156 | 0.013 | 0.156 | Adrenaline agonist | 0.084 0.052 DBMET01397 | ||
| 0.165 | 0.024 | 0.165 | Protein kinase C gamma inhibitor | 0.112 0.06 DBMET01397 | ||
| 0.171 | 0.033 | 0.171 | Antibacterial (Helicobacter pylori) | |||
| 0.187 | 0.05 | 0.187 | MAP kinase kinase 5 inhibitor | 0.159 0.12 DBMET01397 | ||
| 0.141 | 0.005 | 0.141 | Nicotinic acid receptor 1 agonist | 0.094 0.008 DBMET01397 | ||
| 0.202 | 0.068 | 0.202 | Focal adhesion kinase 2 inhibitor | |||
| 0.156 | 0.03 | 0.156 | Alpha 2c adrenoreceptor antagonist | |||
| 0.295 | 0.171 | 0.295 | 5 Hydroxytryptamine release inhibitor | |||
| 0.207 | 0.086 | 0.207 | HERG channel blocker | |||
| 0.14 | 0.018 | 0.14 | 5 Hydroxytryptamine 1F antagonist | 0.071 0.049 DBMET01397 | ||
| 0.244 | 0.127 | 0.244 | Thyroid hormone antagonist | 0.215 0.149 DBMET01397 | ||
| 0.148 | 0.032 | 0.148 | Photosensitizer | |||
| 0.16 | 0.049 | 0.171 | Toll-Like receptor antagonist | 0.171 0.043 DBMET01397 | DBMET01397 | |
| 0.152 | 0.043 | 0.152 | Acetylcholine muscarinic antagonist | 0.098 0.093 DBMET01397 | ||
| 0.218 | 0.11 | 0.218 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.219 | 0.117 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.193 0.188 DBMET01397 | ||
| 0.189 | 0.087 | 0.189 | DNA methylase inhibitor | |||
| 0.125 | 0.024 | 0.125 | Acetylcholine nicotinic agonist | |||
| 0.197 | 0.098 | 0.197 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.121 | 0.023 | 0.121 | Alpha 2d adrenoreceptor antagonist | |||
| 0.104 | 0.01 | 0.104 | Phosphodiesterase 3B inhibitor | 0.059 0.02 DBMET01397 | ||
| 0.191 | 0.099 | 0.191 | ErbB-1 antagonist | 0.182 0.113 DBMET01397 | ||
| 0.248 | 0.157 | 0.248 | Histamine release inhibitor | |||
| 0.103 | 0.012 | 0.103 | Protein kinase C beta inhibitor | |||
| 0.216 | 0.126 | 0.216 | Gastrin inhibitor | 0.201 0.147 DBMET01397 | ||
| 0.179 | 0.089 | 0.179 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.096 | 0.008 | 0.096 | 5 Hydroxytryptamine 1B agonist | 0.077 0.014 DBMET01397 | ||
| 0.173 | 0.085 | 0.173 | DNA methyltransferase I inhibitor | |||
| 0.138 | 0.052 | 0.138 | Platelet activating factor antagonist | |||
| 0.093 | 0.007 | 0.093 | Dopamine D3 agonist | 0.061 0.014 DBMET01397 | ||
| 0.22 | 0.138 | 0.22 | Thyroid hormone beta antagonist | 0.193 0.16 DBMET01397 | ||
| 0.197 | 0.118 | 0.238 | DNA damaging | 0.238 0.087 DBMET01397 | DBMET01397 | |
| 0.108 | 0.028 | 0.108 | Histamine H2 receptor antagonist | 0.084 0.056 DBMET01397 | ||
| 0.163 | 0.084 | 0.163 | Tumour necrosis factor antagonist | |||
| 0.122 | 0.045 | 0.122 | Acetylcholine release stimulant | |||
| 0.137 | 0.06 | 0.137 | Cholinergic antagonist | |||
| 0.135 | 0.059 | 0.135 | Acetylcholine antagonist | |||
| 0.18 | 0.105 | 0.18 | 5 Hydroxytryptamine 3E antagonist | 0.167 0.145 DBMET01397 | ||
| 0.097 | 0.027 | 0.097 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.114 | 0.046 | 0.114 | Pim-1 kinase inhibitor | |||
| 0.14 | 0.075 | 0.14 | MAP3K9 inhibitor | |||
| 0.074 | 0.01 | 0.074 | Alpha 1L adrenoreceptor antagonist | 0.069 0.013 DBMET01397 | ||
| 0.069 | 0.006 | 0.069 | 5 Hydroxytryptamine 1D agonist | |||
| 0.168 | 0.106 | 0.168 | Growth factor agonist | |||
| 0.19 | 0.129 | 0.19 | Cardiotonic | |||
| 0.083 | 0.023 | 0.083 | Phosphodiesterase VII inhibitor | |||
| 0.089 | 0.033 | 0.089 | Alpha adrenoreceptor agonist | |||
| 0.14 | 0.085 | 0.14 | Cholinergic | |||
| 0.068 | 0.013 | 0.068 | Phosphodiesterase 7A inhibitor | |||
| 0.097 | 0.043 | 0.097 | Platelet growth factor antagonist | |||
| 0.079 | 0.024 | 0.079 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.078 | 0.024 | 0.078 | Alpha 1 adrenoreceptor agonist | |||
| 0.128 | 0.075 | 0.128 | Nav1.2 sodium channel blocker | |||
| 0.101 | 0.052 | 0.101 | Interleukin 12 antagonist | |||
| 0.097 | 0.049 | 0.097 | NMDA receptor antagonist | |||
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.104 | 0.058 | 0.104 | Butyrylcholinesterase inhibitor | |||
| 0.106 | 0.06 | 0.106 | MAO A inhibitor | |||
| 0.067 | 0.023 | 0.067 | 5 Hydroxytryptamine 7 agonist | 0.052 0.048 DBMET01397 | ||
| 0.088 | 0.045 | 0.088 | Caspase 7 inhibitor | |||
| 0.069 | 0.027 | 0.069 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.126 | 0.086 | 0.126 | Protein kinase C nu inhibitor | |||
| 0.118 | 0.08 | 0.118 | Acetylcholinesterase inhibitor | |||
| 0.16 | 0.125 | 0.16 | Potassium channel blocker | |||
| 0.038 | 0.008 | 0.038 | Follicle-stimulating hormone agonist | |||
| 0.041 | 0.012 | 0.041 | Cyclin E2 inhibitor | |||
| 0.065 | 0.036 | 0.065 | Acetylcholine M5 receptor antagonist | |||
| 0.062 | 0.034 | 0.062 | Nicotinic neuronal receptor agonist | |||
| 0.064 | 0.037 | 0.064 | Acetylcholine M3 receptor antagonist | |||
| 0.051 | 0.024 | 0.051 | Dopamine D5 antagonist | |||
| 0.056 | 0.03 | 0.056 | Dopamine D4 agonist | |||
| 0.063 | 0.037 | 0.063 | Beta 2 adrenoreceptor agonist | |||
| 0.063 | 0.038 | 0.063 | Protein kinase C iota inhibitor | |||
| 0.059 | 0.035 | 0.059 | Protein kinase C eta inhibitor | |||
| 0.074 | 0.049 | 0.074 | Telomerase inhibitor | |||
| 0.041 | 0.016 | 0.041 | ATM kinase inhibitor | |||
| 0.092 | 0.068 | 0.092 | Platelet activating factor beta antagonist | |||
| 0.091 | 0.068 | 0.091 | Toll-Like receptor 3 antagonist | |||
| 0.107 | 0.084 | 0.107 | MAO inhibitor | |||
| 0.099 | 0.078 | 0.099 | Polo-like kinase-4 inhibitor | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.055 | 0.037 | 0.055 | Nicotinic alpha7 receptor agonist | |||
| 0.06 | 0.042 | 0.06 | Potassium channel (Ca-activated) blocker | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.051 | 0.036 | 0.051 | Glucose-6-phosphate translocase inhibitor | |||
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.097 | 0.085 | 0.097 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.061 | 0.053 | 0.061 | Beta adrenoreceptor antagonist | |||
| 0.072 | 0.064 | 0.072 | Macrophage migration inhibitory factor inhibitor | |||
| 0.067 | 0.06 | 0.067 | MAP3K7 inhibitor | |||
| 0.047 | 0.04 | 0.047 | Beta 2 adrenoreceptor antagonist | |||
| 0.156 | 0.149 | 0.156 | Vasodilator | |||
| 0.077 | 0.07 | 0.077 | Acetylcholine agonist | |||
| 0.146 | 0.14 | 0.146 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.034 | 0.029 | 0.034 | Leukotriene A4 hydrolase inhibitor | |||
| 0.043 | 0.04 | 0.043 | Beta adrenoreceptor agonist | |||
| 0.068 | 0.066 | 0.068 | Phosphodiesterase VI inhibitor | |||
| 0.217 | 0.215 | 0.217 | DNA directed DNA polymerase inhibitor | |||
| 0.065 | 0.063 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.059 | 0.057 | 0.059 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.07 | 0.069 | 0.07 | Estrogen receptor alpha antagonist | |||
| 0.097 | 0.146 | 0.562 | Neurotrophic factor | 0.562 0.003 DBMET01397 | DBMET01397 | |
| 0.076 | 0.187 | 0.181 | Interleukin 1 antagonist | 0.181 0.042 DBMET01397 | DBMET01397 | |
| 0.013 | 0.282 | 0.053 | CC chemokine 5 receptor antagonist | 0.053 0.033 DBMET01397 | DBMET01397 | |
| 0.03 | 0.453 | 0.114 | Interleukin 1b antagonist | 0.114 0.067 DBMET01397 | DBMET01397 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |